Literature DB >> 30466922

The relationships between blood lead levels and serum thyroid stimulating hormone and total thyroxine in the third National Health and Nutrition Examination Survey.

Edward F Krieg1.   

Abstract

Regression analysis was used to estimate and test for relationships between the blood lead concentration and the concentrations of serum thyroid stimulating hormone and serum total thyroxine in adults, 20 years and older, participating in the third National Health and Nutrition Examination Survey. No relationship was found between the blood lead level and the concentration of serum thyroid stimulating hormone. The serum total thyroxine concentration decreased as the blood lead level increased in women, but not in men. The lowest concentration of blood lead at which a relationship could be detected was 2.1 μg/dL and 3.9 μg/dL for the non-pregnant and pregnant women, respectively. Hypothetical mechanisms of the action of lead are discussed. Published by Elsevier GmbH.

Entities:  

Keywords:  Blood lead; NHANES III; Thyroid stimulating hormone; Thyroxine

Mesh:

Substances:

Year:  2018        PMID: 30466922      PMCID: PMC8087148          DOI: 10.1016/j.jtemb.2018.10.010

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  24 in total

1.  Cognitive deficits associated with blood lead concentrations <10 microg/dL in US children and adolescents.

Authors:  B P Lanphear; K Dietrich; P Auinger; C Cox
Journal:  Public Health Rep       Date:  2000 Nov-Dec       Impact factor: 2.792

2.  The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women.

Authors:  Martha Savaria Morris
Journal:  Bone       Date:  2007-01-22       Impact factor: 4.398

3.  A competitive antagonist of thyrotropin: asialo-choriogonadotropin.

Authors:  P Carayon; S Amr; B Nisula
Journal:  Biochem Biophys Res Commun       Date:  1980-11-17       Impact factor: 3.575

4.  Thyroid function and lead: no clear relationship.

Authors:  R M Refowitz
Journal:  J Occup Med       Date:  1984-08

5.  Increased need for thyroxine in women with hypothyroidism during estrogen therapy.

Authors:  B M Arafah
Journal:  N Engl J Med       Date:  2001-06-07       Impact factor: 91.245

6.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Authors:  Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

Review 7.  General background on the hypothalamic-pituitary-thyroid (HPT) axis.

Authors:  R Thomas Zoeller; Shirlee W Tan; Rochelle W Tyl
Journal:  Crit Rev Toxicol       Date:  2007 Jan-Feb       Impact factor: 5.635

8.  Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements.

Authors:  Dana B Barr; Lynn C Wilder; Samuel P Caudill; Amanda J Gonzalez; Lance L Needham; James L Pirkle
Journal:  Environ Health Perspect       Date:  2005-02       Impact factor: 9.031

Review 9.  Toxicokinetics of bone lead.

Authors:  M B Rabinowitz
Journal:  Environ Health Perspect       Date:  1991-02       Impact factor: 9.031

Review 10.  Cellular and molecular toxicity of lead in bone.

Authors:  J G Pounds; G J Long; J F Rosen
Journal:  Environ Health Perspect       Date:  1991-02       Impact factor: 9.031

View more
  1 in total

1.  Are ethnic differences, urinary iodine status, lead and cadmium exposure associated with thyroid autoimmunity and hypothyroid status? A cross-sectional study.

Authors:  Yi Chen; Qian Xiang; Ningjian Wang; Wen Zhang; Chunfang Zhu; Yuying Wang; Heng Wan; Jing Cheng; Kun Zhang; Yan Cai; Yingli Lu
Journal:  BMJ Open       Date:  2022-02-17       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.